Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Jiangsu Nhwa Pharmaceutical Co., LTD
—
Jiangsu Nhwa Pharmaceutical Co., LTD is led by CEO Jiaquan Sun, employs 6,003 people, headquartered in Xuzhou, CN, publicly traded since 2008.
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) stock trades at $21.72 with a market capitalization of $23.02B. The stock is valued at a price-to-earnings (P/E) ratio of 20.85, price-to-book of 2.75, price-to-sales of 3.76. Over the past 52 weeks the stock has ranged between $17.96 and $26.28, and currently trades 17.4% below its 52-week high. It pays a dividend yielding 1.76%.
On profitability, Jiangsu Nhwa Pharmaceutical Co., LTD generates a return on equity (ROE) of 13.68%, an operating margin of 29.40%, a net profit margin of 17.93%.
The balance sheet shows a debt-to-equity ratio of 0.01 (debt below half of shareholders' equity), a current ratio of 6.22.
002262.SZ has an average daily trading volume of 11,311,719 shares, a beta of -0.20, 1.01B shares outstanding.
Official website: www.nhwa-group.com
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) — frequently asked questions
What is Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) stock price today?
Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ) is currently trading at $21.72, up 1.5% today.
What is 002262.SZ P/E ratio?
Jiangsu Nhwa Pharmaceutical Co., LTD's P/E ratio is 20.85. This is between 15x and 30x, around the typical market average of roughly 18-22x.
What is 002262.SZ return on equity (ROE)?
Jiangsu Nhwa Pharmaceutical Co., LTD's return on equity (ROE) is 13.68%. ROE measures net income relative to shareholders' equity. This is within the typical market range of roughly 12-15%.
What is Jiangsu Nhwa Pharmaceutical Co., LTD's market cap?
Jiangsu Nhwa Pharmaceutical Co., LTD has a market capitalization of $23.02B.
Does 002262.SZ pay a dividend?
Yes. Jiangsu Nhwa Pharmaceutical Co., LTD currently yields 1.76%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002262.SZ carry?
Jiangsu Nhwa Pharmaceutical Co., LTD has a debt-to-equity ratio of 0.01. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002262.SZ's profit margin?
Jiangsu Nhwa Pharmaceutical Co., LTD reports a net profit margin of 17.93% — the share of revenue left after every cost, including tax and interest.
What sector is 002262.SZ in?
Jiangsu Nhwa Pharmaceutical Co., LTD is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002262.SZ listed on?
Jiangsu Nhwa Pharmaceutical Co., LTD trades on SHZ under the ticker 002262.SZ.
What is 002262.SZ's 52-week range?
Over the last year Jiangsu Nhwa Pharmaceutical Co., LTD has traded between $17.96 and $26.28.
Related — Stocks
Popular Stocks
Screens 002262.SZ currently matches
On the figures above, Jiangsu Nhwa Pharmaceutical Co., LTD passes the filters for 15 of our ready-made screens, among them Dividend Stocks, S&P 500 Dividend Stocks, Low Debt Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.